Stuart Isaacson, MD - An Expert ’s Perspective on the Diagnosis and Management of Parkinson’s Disease Psychosis in the Long-Term Care Setting
An Expert’s Perspective on the Diagnosis and Management of Parkinson’s Disease Psychosis in the Long-Term Care Setting (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - October 27, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Developing Therapies for Ras-Driven Tumors
NCI's Center for Cancer Research (CCR) Grand Rounds Dr. Cichowski ’ s research goals are to elucidate mechanisms that drive human cancer, identify novel therapeutic targets, and generate robust animal models to facilitate these efforts. A related goal is to establish collaborative relationships with clinicians to translate basic scientific findings into clinical trials. Her principal scientific interest is to understand how the Ras pathway, which is deregulated in the majority of human cancers, promotes tumorigenesis. She and her colleagues have been investigating this question in nervous system tumors, prostate, lung, m...
Source: Videocast - All Events - October 16, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video

Innate Immunity in Neurodegeneration
NCI's Center for Cancer Research (CCR) Grand Rounds Dr. Marco Colonna received his medical degree with honors from the School of Medicine at Parma University in 1983, and completed his specialization in Internal Medicine at Parma University in 1988. He began his postdoctoral training as a Research Fellow at the Istituto Nazionale per la Ricerca sul Cancro in Genova, Italy, followed by work as a Research Affiliate in the Department of Molecular Immunology at Roswell Park Memorial Institute in Buffalo, New York and as a Research Fellow in Pathology at Dana Farber Cancer Institute and Harvard Medical School. He then became a ...
Source: Videocast - All Events - September 25, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video

Aaron Boster, MD - Harnessing the Full Potential of Disease-Modifying Therapy Mechanisms of Action to Improve Outcomes in Multiple Sclerosis
Harnessing the Full Potential of Disease-Modifying Therapy Mechanisms of Action to Improve Outcomes in Multiple Sclerosis (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - September 1, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

CC Grand Rounds: Scientific Advances in the Neurobiological Effects of Mild Traumatic Brain Injury
For more information go tohttp://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 9/6/2017 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - August 25, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video

J. Sloan Manning, MD - Recognition and Treatment of Bipolar Depression: Exploring a Patient ’s Journey From Diagnosis to Treatment
Recognition and Treatment of Bipolar Depression: Exploring a Patient’s Journey From Diagnosis to Treatment (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - August 18, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Edward J. Fox, MD, PhD - Guiding Patients Through the Risks and Benefits of Disease-Modifying Therapy: Patient Stories of Shared Decision-Making Throughout the Course of Multiple Sclerosis
Guiding Patients Through the Risks and Benefits of Disease-Modifying Therapy: Patient Stories of Shared Decision-Making Throughout the Course of Multiple Sclerosis (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - August 9, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Gavin Giovannoni, MBBCH, PhD, FCP, FRCP, FRCPath - Highly Effective Disease-Modifying Therapies for Multiple Sclerosis: When and In Whom Should They Be Used?
Highly Effective Disease-Modifying Therapies for Multiple Sclerosis: When and In Whom Should They Be Used? (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - July 26, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Barry Singer, MD - Examining the Clinical Implications of Late-Breaking Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis Management: What Are the Key Learnings From Boston?
Examining the Clinical Implications of Late-Breaking Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis Management: What Are the Key Learnings From Boston? (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - July 10, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Psychiatric Genomics in the Era of Team Science Symposium
The last decade has seen unprecedented progress in Psychiatric Genomics and for the first-time real advances have been made in delineating the genetic architecture of neuropsychiatric disorders and their underlying molecular pathophysiology. This progress has been facilitated by a convergence in the understanding of the structure and function of the human genome; the development of high throughput sequencing technologies that can be deployed across molecular scales (e.g. DNA, RNA, methylation etc.) and the creation of large bio- and data- repositories. In parallel, the team science (TS) approach has been refined as a novel...
Source: Videocast - All Events - June 15, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video

Michael S. Okun, MD - Moving Toward Optimal Management of Advanced Parkinson ’s Disease: Patient Journeys and Expert Points of View
Moving Toward Optimal Management of Advanced Parkinson’s Disease: Patient Journeys and Expert Points of View (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - May 22, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

J. Sloan Manning, MD - Expert Perspectives on the Journey From the Accurate Identification and Diagnosis to Full Symptom Remission in Patients With Major Depressive Disorder
Expert Perspectives on the Journey From the Accurate Identification and Diagnosis to Full Symptom Remission in Patients With Major Depressive Disorder (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - May 17, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Sea slug brain chemistry reveals a lot about human memory, learning -- Science Nation
As you can imagine, life is not very complicated for sea slugs. They use their brains mainly to find food, avoid becoming food and to reproduce. While the human brain and nervous system are wired with hundreds of billions of nerve cells, or neurons, sea slugs can get by with tens of thousands. ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - May 11, 2017 Category: Science Source Type: video

Extracellular vesicles released by glioblastoma cells: saboteurs, biomarkers and therapeutics
Xandra Breakefield, Ph.D. is a basic scientist with a strong background in molecular genetics and neuroscience. She focuses her research efforts on: gene therapy for neurologic diseases; and elucidation of the role of extracellular vesicles (EVs) released from cancer cells in tumor progression. She led early studies demonstrating mutant RNA in serum EVs from glioblastoma patients as biomarkers.For more information go tohttps://oir.nih.gov/wals/2016-2017/extracellular-vesicles-released-glioblastoma-cells-saboteurs-biomarkersAir date: 5/10/2017 3:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - May 5, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video

Human T cells in immunity, autoimmunity and immunodeficiencies
Immunology Interest Group Seminar Series Dr. Sallusto''s laboratory is focused on the understanding of the mechanisms that control T cell priming and regulate cytokine production and homing capacities. These questions are addressed primarily in the human system, combining the ex vivo analysis of memory T cell subsets with in vitro priming of naive T cells. This approach has led to the identification of chemokine receptors expressed in human Th17 and Th22 cells, and to the dissection of the cytokines that drive naive T cells polarization and modulate T cells effector functions. In parallel, Dr. Sallusto''s laboratory has us...
Source: Videocast - All Events - March 16, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video